Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Research Sites (U24 Clinical Trial Not Allowed)

Forecasted opportunity (not yet open for applications; expected to be posted around 2027-09-01; estimated application due date 2027-11-01). The National Institute of Neurological Disorders and Stroke (NINDS), at the National Institutes of Health (NIH) seek to continue support for the Infrastructure for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT). NeuroNEXT conducts clinical trials and biomarker validation studies for neurological disorders in adult and pediatric populations. By offering infrastructure, expertise, and collaborative opportunities, NeuroNEXT accelerates innovation and impact, advancing the development of safe, effective neurotherapeutics for patients through high-quality evidence pathways. The program will encourage applications for network clinical research sites to support NeuroNEXT.Applications are not being solicited at this time. This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications for clinical research sites.